Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2019 1
2020 6
2021 3
2022 2
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19: A Possible Contribution of the MAPK Pathway.
Cusato J, Manca A, Palermiti A, Mula J, Costanzo M, Antonucci M, Trunfio M, Corcione S, Chiara F, De Vivo ED, Ianniello A, Ferrara M, Di Perri G, De Rosa FG, D'Avolio A, Calcagno A. Cusato J, et al. Among authors: ferrara m. Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459. Biomedicines. 2023. PMID: 37239131 Free PMC article.
A case of treatment-refractory psoriasis as the first manifestation of an HIV-infection.
Boskovic S, Merli M, Dapavo P, Siliquini N, Borriello S, Sciamarrelli N, Aquino C, Mastorino L, Burzi L, Drappero E, Ferrara M, Ribero S, Quaglino P. Boskovic S, et al. Among authors: ferrara m. Ital J Dermatol Venerol. 2024 Feb;159(1):68-69. doi: 10.23736/S2784-8671.23.07656-9. Epub 2023 Nov 28. Ital J Dermatol Venerol. 2024. PMID: 38015571 No abstract available.
Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV.
Ferrara M, Cusato J, Salvador E, Trentalange A, Alcantarini C, Trunfio M, Cannizzo ES, Bono V, Nozza S, De Nicolò A, Ianniello A, De Vivo E, D'Avolio A, Di Perri G, Bonora S, Marchetti G, Calcagno A. Ferrara M, et al. Br J Clin Pharmacol. 2023 Mar;89(3):1020-1026. doi: 10.1111/bcp.15538. Epub 2022 Oct 11. Br J Clin Pharmacol. 2023. PMID: 36115063 Free article.
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry.
Saladini F, Giammarino F, Maggiolo F, Ferrara M, Cenderello G, Celesia BM, Martellotta F, Spagnuolo V, Corbelli GM, Gianotti N, Santoro MM, Rusconi S, Zazzi M, Castagna A; PRESTIGIO Study Group. Saladini F, et al. Among authors: ferrara m. Int J Antimicrob Agents. 2023 Mar;61(3):106737. doi: 10.1016/j.ijantimicag.2023.106737. Epub 2023 Jan 25. Int J Antimicrob Agents. 2023. PMID: 36708743
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy.
Bozzi G, Fabeni L, Abbate I, Berno G, Muscatello A, Taramasso L, Fabbiani M, Nozza S, Tambussi G, Rusconi S, Giacomelli A, Focà E, Pinnetti C, d'Ettorre G, Mussini C, Borghi V, Celesia BM, Madeddu G, Di Biagio A, Ripamonti D, Squillace N, Antinori A, Gori A, Capobianchi MR, Bandera A; INACTION study group. Bozzi G, et al. Sex Transm Infect. 2023 Feb;99(1):53-56. doi: 10.1136/sextrans-2021-055289. Epub 2022 Apr 20. Sex Transm Infect. 2023. PMID: 35443987 Free article.
Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort.
Focà E, Calcagno A, Calza S, Renzetti S, Chiesa A, Siano M, De Socio G, Piconi S, Orofino G, Madeddu G, Cattelan AM, Nozza S, Ferrara M, Milic J, Celesia BM, Castelli F, Guaraldi G. Focà E, et al. Among authors: ferrara m. PLoS One. 2021 Oct 13;16(10):e0258533. doi: 10.1371/journal.pone.0258533. eCollection 2021. PLoS One. 2021. PMID: 34644336 Free PMC article.
22 results